Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Germany
/
Healthcare
Create a narrative
Drägerwerk KGaA Community
XTRA:DRW3 Community
3
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Community Investing Ideas
Drägerwerk KGaA
Popular
Undervalued
Overvalued
Drägerwerk KGaA
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Aging Populations And Digital Health Will Transform Global Demand
Key Takeaways Strong order backlog, operational streamlining, and digitization efforts position the company for sustained growth, margin expansion, and resilience amid external headwinds. Expansion in emerging markets and a growing defense pipeline enable geographically diverse, high-margin revenue streams with first-mover advantages in smart healthcare infrastructure.
View narrative
€96.00
FV
29.8% undervalued
intrinsic discount
5.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Drägerwerk KGaA
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Regulatory Burdens And Procurement Consolidation Will Weaken Operating Margins
Key Takeaways Rising regulatory burdens and healthcare consolidation will push up costs, strain margins, and erode pricing power against larger global competitors. Dependence on mature products and high fixed costs heighten risks of revenue stagnation, unpredictable earnings, and lagging operational efficiency.
View narrative
€63.00
FV
7.0% overvalued
intrinsic discount
3.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
Drägerwerk KGaA
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Global Medical Demand Will Unlock Future Markets
Key Takeaways Strengthened demand for advanced medical and safety products, along with digital solution adoption, is set to drive steady, long-term revenue and margin growth. Operational consolidation and strategic pricing are improving cost efficiency and helping offset headwinds, supporting stable earnings and sustainable profitability.
View narrative
€76.60
FV
12.0% undervalued
intrinsic discount
4.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
DRW3
DRW3
Drägerwerk KGaA
Your Fair Value
€
Current Price
€67.40
11.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-83m
4b
2015
2018
2021
2024
2025
2027
2030
Revenue €4.1b
Earnings €120.4m
Advanced
Set Fair Value